Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated Lp(a) and CAC in MESA and DHS. See my take and how a primary prevention CVOT might be performed. https://t.co/OiqsaRMaVE https://t.co/TSeS8ZcN3v https://t.co/ZVx9q8d3Qp
Lipoprotein(a) and Coronary Calcium: Clinical Management and Potential Design of Primary Prevention Trials.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Feb 2022 – Jul 2023Where it's discussed
-
X / Twitter36 posts
-
News5 articles
-
YouTube2 videos
AI synopsis
What people are saying
The discussions highlight the significance of the article by referencing key studies like Mehta et al. and editorial comments from experts such as Dr. Tsimikas, which convey a sense of enthusiasm and importance. The tone varies from supportive to analytical, emphasizing that the publication could shape future prevention trials and clinical decisions related to lipid and calcium markers.
Most discussions support the importance of the research, referencing studies and experts positively.
Posts show high enthusiasm for new findings, emphasizing the relevance of lipoprotein(a) and coronary calcium in risk assessment.
Users actively share links, comment on studies, and mention editorial insights, indicating meaningful engagement.
The discussions reflect a recognition of the potential influence on clinical practice, particularly in prevention strategies.
Abstract in brief
- This text discusses the role of lipoproteins (like LDL cholesterol) and coronary calcium in assessing the risk of heart disease, focusing on how they can help guide clinical decisions for preventing heart attacks.
- It reviews current strategies for managing patients based on lipid levels and coronary artery calcification, aiming to improve prevention methods for high-risk individuals.
- The article also explores how future prevention trials might be designed, considering these markers to better evaluate new treatments and interventions for reducing coronary artery disease.]
Top posts
Most liked on X and BlueskyClarification, CAC=0 generally has excellent prognosis for short term risk. For high Lp(a), CAC=0 is not entirely protective, but risk is much lower than if CAC is >100. See my editorial on this. https://t.co/GNCMMJe7aP https://t.co/1deHK7zMp5
@MichaelJBlaha @virani_md Please read the accompanying wonderful editorial by Lp(a) Guru, Dr. Tsimikas @Lpa_Doc https://t.co/yZzHRagidx
Lipoproteína(a) y calcio coronario: manejo clínico y diseño potencial de ensayos de prevención primaria.@sea_es https://t.co/6MDrZx6DWz
@Lpa_Doc https://t.co/0urwz63Sdq …If you are having issues with the original link, as I had. Thanks @Lpa_Doc
RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…
All mentions
Debunking 5 Myths About the Coronary Calcium Score in Heart Disease Risk
Understanding Coronary Artery Calcium Scores and Heart Health
A zero coronary artery calcium (CAC) score indicates a low risk of heart disease, suggesting minimal calcium buildup in the arteries. However, it doesn't eliminate the possibility of cardiovascular issues. It's…
@MattyParks12 @5MinuteBody i'm gonna start pasting lotsa links to real science seeing people seem to be unable to find the info and have zero critical thinking skills https://t.co/RigwLKD3Pm https://t.co/DScmG6wqw2 https://t.co/E53mun18co https://t.co/0Rc1FiUhvz
Clarification, CAC=0 generally has excellent prognosis for short term risk. For high Lp(a), CAC=0 is not entirely protective, but risk is much lower than if CAC is >100. See my editorial on this. https://t.co/GNCMMJe7aP https://t.co/1deHK7zMp5
RT @TeresaArrobas: Lipoproteína(a) y calcio coronario: manejo clínico y diseño potencial de ensayos de prevención primaria.@sea_es https:/…
Lipoproteína(a) y calcio coronario: manejo clínico y diseño potencial de ensayos de prevención primaria.@sea_es https://t.co/6MDrZx6DWz
RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…
RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…
RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…
RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…
RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…
RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…
RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…
RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…
RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…
RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…
RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…
RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…
RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…
RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…
RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…
RT @NEVasquez92: @MichaelJBlaha @virani_md Please read the accompanying wonderful editorial by Lp(a) Guru, Dr. Tsimikas @Lpa_Doc https://t…
RT @NEVasquez92: @MichaelJBlaha @virani_md Please read the accompanying wonderful editorial by Lp(a) Guru, Dr. Tsimikas @Lpa_Doc https://t…
RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…
RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…
@Lpa_Doc https://t.co/0urwz63Sdq …If you are having issues with the original link, as I had. Thanks @Lpa_Doc
RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…
RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…
RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…
RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…
RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…
RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…
RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…
RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…
RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…
RT @Lpa_Doc: Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated L…
Lp(a) papers are coming our fast and furious from @JACCJournals. Mehta et al performed an elegant study on risk of elevated Lp(a) and CAC in MESA and DHS. See my take and how a primary prevention CVOT might be performed. https://t.co/OiqsaRMaVE https://t.co/TSeS8ZcN3v https://t.co/ZVx9q8d3Qp
@MichaelJBlaha @virani_md Please read the accompanying wonderful editorial by Lp(a) Guru, Dr. Tsimikas @Lpa_Doc https://t.co/yZzHRagidx